Pandemic Influenza Plan - Questar III

More documents

Recommendations

Info

Section 13: Public Health Preparedness Informatics • Digital Photograph submittal. Allows health facilities to submit a digital photograph of a suspect case for review by a medical epidemiologist. Submittal of a photograph initiates an electronic workflow for review of the image and correspondence with the submitter and triggers IHANS to notify State Epidemiology staff and the duty officer system. The HAN Web site is located at: https://commerce.health.state.ny.us/hpn/hanweb/hanhome.shtml h. Secure Collaboration. A secure discussion forum system is available on the commerce system. The forum provides for open or access controlled discussion groups to be set up on the fly and controlled by a moderator, allowing members to post files and carry on secure collaborative discussion topics. On activation of an electronic incident (different from a survey or surveillance form) in HERDS a secure access controlled discussion group is automatically created and access granted to the affected facilities and jurisdictions. The discussion forum is available at: https://commerce.health.state.ny.us/frm/cgi-bin/applinks/forum/WebX i. Secure file transfer. Files may be securely transmitted between any two commerce users. Files sent by a user are virus scanned and sent to an electronic drop box, the recipient is notified by e-mail on arrival. The sender is notified by e-mail that he recipient has downloaded the file. The utility is available at: https://commerce.health.state.ny.us/hpn/ctrldocs/genfxr/filetransfer.html j. Data Analysis and Visualization (DAV). • Geographical Information System (GIS). Commerce system supports spatial DAV through a web enabled COTS GIS viewer system (ESRI/ARCIMS). Basic geographic layers (e.g., transportation, geopolitical boundaries, place locations, water boundaries), heath-response related point locations (e.g., health facility locations) and health data layers are available through the commerce spatial data warehouse (ERSI). The GIS viewer system integrates with HERDS and supports full featured queries and display of any reporting system deployed in HERDS. Hospital assets, vaccine inventory and influenza surveillance functions listed above are available in real time for GIS DAV. This capacity will be available for other HERDS instances for other facilities and LHDs in Q1 of 2006. A GIS capacity also exists for CEDSS and this will be migrated to the generalized GIS viewer in the sale timeframe. The HERDS GIS Viewer is located at: https://commerce.health.state.ny.us/map/doh2/applinks/hospcap/new/ • Executive DashBoard (EDB). An executive dashboard system is available for just-in-time activation and use in a PHP event. The dashboard provides an integrated portal providing summary visualization of key information systems on health commerce to provide executive decision makers with high-level situational awareness and decision support. It also provides February 7, 2006 13-12
Section 13: Public Health Preparedness Informatics access to key functions (ComDir, alerting and secure collaboration) from a single web interface. On activation the IHANS system will be used to distribute links to the EDB for key ComDir roles within the affected organizations. • Report Tables, Charts, Graphs. Event specific report tables, charts and graphs are produced by an automated SAS interface to HERDS and other response data systems. A generalized viewer is available for just-in-time access to this information. On activation, the link to the viewer will be sent to key ComDir roles in affected organizations using the IHANS system. A more generalized system for data visualization and dynamic queries for tables and charts will be available for use in Q1 2006. 5. Disease Surveillance – and Related Commerce Systems a. Nosocomial Outbreak and Reporting Application (NORA). Provides for general reporting of Nosocomial (i.e., health facility acquired) outbreak incidents at health facilities (nursing homes and hospitals), respiratory (ILI, influenza) being one of the reporting capacities. The NORA Application is available on the Infection Control Home Page: https://commerce.health.state.ny.us/hpn/infecontrol/infecontrol.html b. Electronic Clinical Laboratory Reporting System (ECLRS). Health Commerce has supported a statewide electronic lab reporting system (ECLRS) for (positive) laboratory test results for NYS reportable disease conditions. The system supports electronic submission via web form, file upload of standardized messages and automated transmission using the CDC PHIN standards messaging system (EbXML). Message formats and syntax accepted include HL7 with LOINC/SNOMED vocabulary. Flattened formats are also available for labs who do not yet support the standards. Some 260 labs report Communicable diseases electronically to ECLRS, including national labs such as Quest and Lab Corp. Lab test results received from labs by ECLRS are automatically and electronically routed to the county of jurisdiction. Sixteen reportable diseases are designated as priority notification which triggers an automated phone call 24/7 to the county of jurisdiction alerting them to the case. ECLRS links to the Communicable Disease surveillance system. c. Communicable Disease Electronic Surveillance System (CDESS). The Health Commerce system has supported a web based statewide electronic communicable disease reporting system since 1996. It provides for case reporting of all NYS reportable disease conditions using an electron version of the DOH-389 core form. Reporting includes various reportable influenza conditions. Electronic reporting of disease-specific supplemental forms is also supported through the system. The system has recently been revised to a patient centric reporting system which supports contact tracing and minimal isolation and quarantine for SARS and (novel virus) pandemic influenza. ECLRS is integrated into the system. February 7, 2006 13-13
Page 1 and 2:
February206 Pandemic Plan NewYorkSt
Page 3 and 4:
Introduction Pandemic influenza occ
Page 5 and 6:
example, at this time, it is realis
Page 7 and 8:
Acronyms (cont.) IND IHANS IRB ISHS
Page 9 and 10:
Section 1: Command and Control I. O
Page 11 and 12:
Section 1: Command and Control pers
Page 13 and 14:
February 7, 2006 Appendix 1-A
Page 15 and 16:
Appendix 1-B The Public Health Law
Page 17 and 18:
Appendix 1-B communicable diseases
Page 19 and 20:
Appendix 1-C Management Office or t
Page 21 and 22:
Appendix 1-E Suspension of Public M
Page 23 and 24:
Appendix 1-G A Guide to New York St
Page 25 and 26:
Appendix 1-G health commissioner. P
Page 27 and 28:
Appendix 1-G 8. State Institutions
Page 29 and 30:
Appendix 1-G b. Governor May Invoke
Page 31 and 32:
Appendix 1-G may direct, pursuant t
Page 33 and 34:
Appendix 1-G c. Commissioner of Gen
Page 35 and 36:
Appendix 1-G Designation of emergen
Page 37 and 38:
Appendix 1-G physician’s assistan
Page 39 and 40:
Appendix 1-H Summary of Public Offi
Page 41 and 42:
Section 2: Surveillance and Laborat
Page 43 and 44:
Page 45 and 46:
Page 47 and 48:
Page 49 and 50:
Page 51 and 52:
Page 53 and 54:
Page 55 and 56:
Page 57 and 58:
Page 59 and 60:
Page 61 and 62:
Page 63 and 64:
Appendix 2-A • Surveillance Crite
Page 65 and 66:
Appendix 2-A • In New York City,
Page 67 and 68:
NYSDOH Novel Influenza Case Report
Page 69 and 70:
Page 71 and 72:
Page 73 and 74:
Appendix 2-C to health care provide
Page 75 and 76:
Virus Detection History NYS Lab Num
Page 77 and 78:
Section 3: Healthcare Planning and
Page 79 and 80:
Page 81 and 82:
Page 83 and 84:
Page 85 and 86:
Page 87 and 88:
Page 89 and 90:
Page 91 and 92:
Page 93 and 94:
Page 95 and 96:
Page 97 and 98:
Page 99 and 100:
Page 101 and 102:
Page 103 and 104:
Page 105 and 106:
Page 107 and 108:
Page 109 and 110:
Page 111 and 112:
Page 113 and 114:
Page 115 and 116:
Page 117 and 118:
Page 119 and 120:
Page 121 and 122:
Page 123 and 124:
Page 125 and 126:
Section 4: Infection Control I. Ove
Page 127 and 128:
Section 4: Infection Control I. Ove
Page 129 and 130:
Section 4: Infection Control A. Bas
Page 131 and 132:
Section 4: Infection Control Drople
Page 133 and 134:
Section 4: Infection Control • Pe
Page 135 and 136:
Section 4: Infection Control o Noti
Page 137 and 138:
Section 4: Infection Control E. Coh
Page 139 and 140:
Section 4: Infection Control If wid
Page 141 and 142:
Section 4: Infection Control • En
Page 143 and 144:
Section 4: Infection Control should
Page 145 and 146:
Section 4: Infection Control Policy
Page 147 and 148:
Section 4: Infection Control o Staf
Page 149 and 150:
Section 4: Infection Control • De
Page 151 and 152:
Section 4: Infection Control • Pr
Page 153 and 154:
Section 4: Infection Control The ma
Page 155 and 156:
Section 4: Infection Control • Up
Page 157 and 158:
Section 4: Infection Control Health
Page 159 and 160:
Appendix 4-A Soiled linen and laund
Page 161 and 162:
Appendix 4-B Respiratory Hygiene/Co
Page 163 and 164:
Section 5: Clinical Guidelines I. O
Page 165 and 166:
Section 5: Clinical Guidelines incu
Page 167 and 168:
Section 5: Clinical Guidelines 1) N
Page 169 and 170:
Section 5: Clinical Guidelines infe
Page 171 and 172:
Section 5: Clinical Guidelines Alth
Page 173 and 174:
Section 5: Clinical Guidelines Infe
Page 175 and 176:
Section 5: Clinical Guidelines •
Page 177 and 178:
Appendix 5-B Clinical Evaluation of
Page 179 and 180:
Appendix 5-C Special Situations and
Page 181 and 182:
Appendix 5-D handling soiled laundr
Page 183 and 184:
DRAFT Appendix 5-E Footnotes to App
Page 185 and 186:
Appendix 5-F February 7, 2006 1
Page 187 and 188:
Appendix 5-F 7. Guidance on the eva
Page 189 and 190:
Appendix 5-H Source: U.S. Departmen
Page 191 and 192:
February 7, 2006 2 Appendix 5-I
Page 193 and 194:
Appendix 5-J Clinical Presentation
Page 195 and 196:
Appendix 5-J diabetes mellitus), re
Page 197 and 198:
Appendix 5-J resistant S. aureus (M
Page 199 and 200:
Appendix 5-K eight patients—all o
Page 201 and 202:
Appendix 5-L Guidelines for Managem
Page 203 and 204:
Appendix 5-L testing should be perf
Page 205 and 206:
Appendix 5-L February 7, 2006 5
Page 207 and 208:
Section 6: Vaccine Procurement, Dis
Page 209 and 210:
Page 211 and 212:
Page 213 and 214:
Page 215 and 216:
Page 217 and 218:
Page 219 and 220:
Appendix 6-A Vaccine Priority Group
Page 221 and 222:
Appendix 6-B Mass Clinic Planning O
Page 223 and 224:
Appendix 6-C Vaccine and Antiviral
Page 225 and 226:
Appendix 6-C 1. Request Phase The r
Page 227 and 228:
Appendix 6-C 3. Receipt and Sign-of
Page 229 and 230:
Appendix 6-C • Work with local he
Page 231 and 232:
Section 7: Antiviral Medication Pro
Page 233 and 234:
Page 235 and 236:
Page 237 and 238:
Page 239 and 240:
Page 241 and 242:
Page 243 and 244:
Page 245 and 246:
Page 247 and 248:
Page 249 and 250:
Appendix 7-A Characteristics of Ant
Page 251 and 252:
Appendix 7-B a The drug package ins
Page 253 and 254:
Appendix 7-C 7 HCWs in emergency de
Page 255 and 256:
Section 8: Travel-Related Disease C
Page 257 and 258:
Page 259 and 260:
Page 261 and 262:
Page 263 and 264:
Page 265 and 266:
Page 267 and 268:
Appendix 8-A Home or Community-Base
Page 269 and 270:
Appendix 8-B Contact Identification
Page 271 and 272:
Appendix 8-B • Determine the time
Page 273 and 274:
Appendix 8-C Administrative Data: S
Page 275 and 276:
Appendix 8-D CONTACT DAILY TEMPERAT
Page 277 and 278:
Appendix 8-F Definitions: Intervent
Page 279 and 280:
Appendix 8-F facility. No specific
Page 281 and 282:
Appendix 8-F • Resources Required
Page 283 and 284:
Appendix 8-G Business Pandemic Infl
Page 285 and 286:
Appendix 8-G 4. Allocate resources
Page 287 and 288:
Appendix 8-H CDC guidelines suggest
Page 289 and 290:
Appendix 8-H If I am not masked I
Page 291 and 292:
Appendix 8-H NYSDOH Model Influenza
Page 293 and 294:
Appendix 8-H I understand that if
Page 295 and 296:
Section 9: Communications I. Overvi
Page 297 and 298:
Section 9: Communications and commu
Page 299 and 300:
Section 9: Communications web pages
Page 301 and 302:
Section 9: Communications Local Hea
Page 303 and 304:
Section 9: Communications • A JIC
Page 305 and 306:
Section 9: Communications backup to
Page 307 and 308:
Section 9: Communications • In th
Page 309 and 310:
Appendix 9-A Public Health Risk Com
Page 311 and 312:
Appendix 9-C New York State Departm
Page 313 and 314:
Appendix 9-C PRE-EVENT MESSAGE MAP:
Page 315 and 316: Appendix 9-C PROTECTIVE MESSAGE MAP
Page 317 and 318: Appendix 9-C TREATMENT MESSAGE MAP:
Page 319 and 320: Appendix 9-C BUSINESS CONTINUITY PR
Page 321 and 322: Section 10: Training and Education
Page 327 and 328: Appendix 10-A NYSDOH STAFF PRIVATE
Page 335 and 336: FACILITY- BASED RNs FACILITY- BASED
Page 341 and 342: Section 11: Workforce Support I. Ov
Page 343 and 344: Section 11: Workforce Support Pande
Page 345 and 346: Section 12: Highly Pathogenic H5N1
Page 347 and 348: Section 12: H5N1 in Non-Human Anima
Page 355 and 356: Section 13: Public Health Preparedn
Page 365: Section 13: Public Health Preparedn
Page 389 and 390: Appendix 13-A NYSDOH Roles Notified
Page 391 and 392: Appendix 13-B Notifications sent by
Page 393 and 394: Appendix 13-B HAN posting is used a
Page 395 and 396: Appendix 13-B notification system t
Page 397 and 398: Appendix 13-C Overview of the Healt
Page 399 and 400: Appendix 13-C • Ongoing surveilla
Page 401 and 402: Table 1. Summary of HERDS Use To da
Page 403 and 404: Appendix 13-D Commerce Access and A
Page 405 and 406: Appendix 13-D Table 3. Organization
show all

Pandemic Influenza Plan - Questar III

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?